Source Natural Foods Faces Valuation Shift Amid Mixed Financial Indicators
Source Natural Foods & Herbal Supplements has recently adjusted its valuation metrics, reflecting a change in its market position within the Pharmaceuticals & Drugs industry. Key financial indicators, including a high price-to-earnings ratio and a notable return on equity, underscore the complexities of the company's financial landscape.
Source Natural Foods & Herbal Supplements has recently undergone an evaluation adjustment, reflecting a shift in its valuation metrics. The company, operating within the Pharmaceuticals & Drugs industry, has seen its valuation grade transition from fair to expensive. This adjustment is primarily attributed to key financial indicators that suggest a notable change in the company's market position.The stock currently exhibits a price-to-earnings (PE) ratio of 45.10 and a price-to-book value of 5.69, which are significant metrics in assessing its valuation relative to peers. Additionally, the enterprise value to EBITDA stands at 21.49, indicating a higher valuation compared to industry averages. Despite a robust return of 105.51% over the past year, the company's profits have experienced a slight decline of 2.3%, raising questions about sustainability in its current valuation.
Furthermore, Source Natural maintains a strong return on equity (ROE) of 12.62%, coupled with a low debt-to-equity ratio, suggesting effective management efficiency. However, the elevated PEG ratio of 30.52 indicates that growth expectations may be priced into the stock.
As the company navigates these dynamics, the recent evaluation adjustment highlights the complexities of its financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
